サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566952

ビリルビン測定器市場：製品別、適応症別、年齢層別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年

Bilirubin Meters Market By Product , By Indication By Age Group By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 280 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
ビリルビン測定器市場：製品別、適応症別、年齢層別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 280 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ビリルビン測定器市場は2023年に12億米ドルと評価され、2024年から2033年にかけてCAGR 7.6%で成長し、2033年には25億米ドルに達すると予測されています。

ビリルビン測定器は、主に新生児の血中ビリルビン濃度を測定するために設計されたハンドヘルド医療機器です。ビリルビン値の上昇は黄疸につながる可能性があり、これは乳幼児によく見られる症状で、放置すると脳障害を含む深刻な健康問題を引き起こす可能性があります。これらの測定器は、非侵襲的で迅速かつ正確にビリルビン値をモニターする方法を提供し、早期発見と治療を可能にします。そのため、新生児ケアにおいて重要な役割を果たし、ヘルスケア専門家がさらなる検査や介入の必要性について十分な情報を得た上で意思決定するのに役立っています。

世界のビリルビン測定器市場の成長は、新生児黄疸の憂慮すべき有病率の上昇と、新生児の黄疸の早期診断と治療を重視し、ケルニクテルスなどの合併症を予防することの増加によって牽引されています。サイエンス・ダイレクト社が2024年1月に発表した研究によると、世界中で年間約110万人の新生児が高ビリルビン血症を発症しており、2,000万人以上が高ビリルビン血症関連の合併症の危険にさらされています。さらに、黄疸を起こしやすい早産児の増加が、ビリルビン測定器の需要を高めています。これは、未熟児はしばしばより綿密なモニタリングを必要とするため、ビリルビン測定器が新生児集中治療室に不可欠であるという事実に起因しています。世界保健機関（WHO）によると、2020年には約1,340万人の早産が報告されています。さらに、乳幼児死亡率の低下と新生児の健康増進を目的とした政府のイニシアティブの高まりが、ビリルビン測定器の採用を後押ししており、これが世界市場の主要な原動力となっています。経皮法を用いて皮膚を通してビリルビン値を測定する非侵襲性ビリルビン測定器へのシフトは、世界市場の成長を強化している現在の動向です。これらの機器は採血の必要性を減らし、新生児にとってストレスの少ないプロセスとなり、ヘルスケアプロバイダーにとっても効率的です。非侵襲的なデジタルビリルビン測定器には大きな利点があるが、特に低所得地域や小規模なヘルスケア施設では、その高コストが導入の障壁となり、市場成長の妨げとなっています。加えて、定期的なビリルビンモニタリングの重要性やビリルビン測定器の使用に関する医療従事者の認識やトレーニングの不足は、市場の主要な阻害要因として作用します。それに対して、メーカーは、コンパクトで使いやすく、病院、診療所、さらには在宅医療を含む様々な環境で使用できるように設計された、ポータブルおよびポイント・オブ・ケア型ビリルビン測定器の開発に注力しています。さらに、センサー技術の革新は、より正確で信頼性の高いビリルビン測定器につながっています。このような進歩には、マルチスペクトルセンサーや、肌の色が濃い乳児でも正確な測定ができるアルゴリズムの使用が含まれ、旧型装置のこれまでの限界に対処しています。このような発展は、市場成長に有利な機会を提供すると期待されています。

世界のビリルビン測定器産業は、製品、適応症、年齢層、エンドユーザー、地域に区分されます。製品別では、市場はベンチトップ型と経皮型に分けられます。適応症別では、黄疸と肝炎に分けられます。年齢層別では、新生児と成人に分類されます。エンドユーザー別では、病院・介護施設、診療所、その他に分類されます。地域別では、市場は北米、欧州、アジア太平洋、LAMEAで分析されます。

主な調査結果

製品別では、経皮セグメントが2023年の市場シェアを独占。

適応症別では、黄疸セグメントが2023年の主要株主でした。

年齢層別では、新生児が2023年の主要セグメントとして浮上しました。

エンドユーザー別では、病院・介護施設が2023年の主要セグメントに浮上しました。

地域別では、北米が2023年に最大シェアを獲得したが、アジア太平洋が予測期間中に最も高いCAGRを記録すると予想されます。

本レポートのカスタマイズが可能です。

  • 規制ガイドライン
  • 顧客の関心に応じた企業プロファイルの追加
  • 国別または地域別の追加分析-市場規模と予測
  • 企業プロファイルの拡張リスト
  • 過去の市場データ
  • 主要プレーヤーの詳細（所在地、連絡先、サプライヤー／ベンダーネットワークなどを含む、エクセル形式）

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 ビリルビン測定器市場：製品別

  • 市場概要
  • ベンチトップ型
  • 経皮

第5章 ビリルビン測定器市場：適応症別

  • 市場概要
  • 黄疸
  • 肝炎

第6章 ビリルビン測定器市場：年齢層別

  • 市場概要
  • 新生児
  • 成人

第7章 ビリルビン測定器市場：エンドユーザー別

  • 市場概要
  • 病院と老人ホーム
  • 診療所
  • その他

第8章 ビリルビン測定器市場：地域別

  • 市場概要
  • 北米
    • 主な市場動向と機会
    • 米国のビリルビン測定器市場
    • カナダのビリルビン測定器市場
    • メキシコのビリルビン測定器市場
  • 欧州
    • 主な市場動向と機会
    • ドイツのビリルビン測定器市場
    • フランスのビリルビンメーター市場
    • 英国のビリルビンメーター市場
    • イタリアのビリルビンメーター市場
    • スペインのビリルビンメーター市場
    • その他欧州のビリルビン測定器市場
  • アジア太平洋
    • 主な市場動向と機会
    • 日本のビリルビン測定器市場
    • 中国のビリルビン測定器市場
    • オーストラリアのビリルビンメーター市場
    • インドのビリルビンメーター市場
    • 韓国のビリルビン測定器市場
    • その他アジア太平洋のビリルビン測定器市場
  • ラテンアメリカ・中東・アフリカ
    • 主要市場動向と機会
    • ブラジルのビリルビン測定器市場
    • サウジアラビアのビリルビン測定器市場
    • 南アフリカのビリルビン測定器市場
    • その他のラテンアメリカ・中東・アフリカのビリルビン測定器市場

第9章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第10章 企業プロファイル

  • APEL Co. Ltd
  • Dragerwerk AG And Co. KGaA
  • Mennen Medical Ltd
  • Micro Lab Instruments
  • Ningbo David Medical Device Co. Ltd
  • Siemens Healthineers AG
  • Micro Labs Instruments
  • AVI Healthcare Pvt Ltd
  • F. Hoffmann-La Roche Ltd.
  • Koninklijke Philips N.V.
目次
Product Code: A324070

The bilirubin meters market was valued at $1.2 billion in 2023, and is projected to reach $2.5 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033.

Bilirubin meter is a handheld medical device designed to measure the levels of bilirubin in the blood, primarily in newborns. Elevated bilirubin levels can lead to jaundice, a common condition in infants that, if left untreated, can cause serious health issues, including brain damage. These meters provide a non-invasive, quick, and accurate method for monitoring bilirubin levels, enabling early detection and treatment. Thus, they play a critical role in neonatal care, helping healthcare professionals make informed decisions about the need for further testing or interventions.

The growth of the global bilirubin meters market is driven by alarming rise in prevalence of neonatal jaundice and increase in emphasis on early diagnosis and treatment of jaundice in newborns to prevent complications such as kernicterus. According to a study published by Science Direct in January 2024, approximately 1.1 million babies worldwide develop hyperbilirubinemia yearly; over 20 million are at risk of hyperbilirubinemia-related complications. Furthermore, rise in the number of preterm births, which are more susceptible to jaundice, is contributing to the demand for bilirubin meters. This is attributed to the fact that premature infants often require closer monitoring, making bilirubin meters essential in neonatal intensive care units. As per the World Health Organization, approximately 13.4 million preterm births were reported in 2020. Furthermore, rise in government initiatives aimed at reducing infant mortality and improving neonatal health is encouraging the adoption of bilirubin meters, which acts as the key driving force of the global market. Shift toward non-invasive bilirubin meters, which measure bilirubin levels through the skin using transcutaneous methods, is the current trend that is strengthening the growth of the global market. These devices reduce the need for blood draws, making the process less stressful for newborns and more efficient for healthcare providers. Although non-invasive and digital bilirubin meters offer significant benefits, their high cost can be a barrier to adoption, particularly in low-income regions and smaller healthcare facilities, thereby hampering the market growth. In addition, lack of awareness and training among healthcare providers regarding the importance of regular bilirubin monitoring and the use of bilirubin meters acts as a key deterrent factor of the market. On the contrary, manufacturers are focusing on the development of portable and point-of-care bilirubin meters, which are compact, easy to use, and designed for use in various settings, including hospitals, clinics, and even in-home care. Furthermore, innovations in sensor technology are leading to more accurate and reliable bilirubin meters. These advancements include the use of multispectral sensors and algorithms that provide precise measurements, even in infants with darker skin tones, addressing previous limitations of older devices. Such developments are expected to offer lucrative opportunities for the market growth.

The global bilirubin meters industry is segmented into product, indication, age group, end user, and region. By product, the market is divided into bench-top and transcutaneous. On the basis of indication, it is segregated into jaundice and hepatitis. As per age group, it is classified into neonatal and adults. Depending on end user, it is segregated into hospitals & nursing home, clinics, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product, the transcutaneous segment dominated the market share in 2023.

On the basis of indication, the jaundice segment was the major shareholder in 2023.

As per age group, neonatal emerged as the leading segment in 2023.

Depending on end user, hospitals & nursing home emerged as the leading segment in 2023.

Region wise, North America garnered maximum share in 2023; however, Asia-Pacific is expected to register highest CAGR during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global bilirubin meters market include APEL Co. Ltd., Dragerwerk AG & Co. KGaA, Mennen Medical Ltd, Micro Lab Instruments, Ningbo David Medical Device Co. Ltd., Siemens Healthineers AG, Micro Labs Instruments, AVI Healthcare Pvt Ltd, F. Hoffmann-La Roche Ltd., and Koninklijke Philips N.V. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

By Product

  • Bench-Top
  • Transcutaneous

By Indication

  • Jaundice
  • Hepatitis

By Age Group

  • Neonatal
  • Adults

By End User

  • Hospitals and Nursing Home
  • Clinics
  • Others

Key Market Players:

    • APEL Co. Ltd
    • Dragerwerk AG & Co. KGaA
    • Mennen Medical Ltd
    • Micro Lab Instruments
    • Ningbo David Medical Device Co. Ltd
    • Siemens Healthineers AG
    • Micro Labs Instruments
    • AVI Healthcare Pvt Ltd
    • F. Hoffmann-La Roche Ltd.
    • Koninklijke Philips N.V.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: BILIRUBIN METERS MARKET, BY PRODUCT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product
  • 4.2. Bench-Top
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Transcutaneous
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: BILIRUBIN METERS MARKET, BY INDICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Indication
  • 5.2. Jaundice
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Hepatitis
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: BILIRUBIN METERS MARKET, BY AGE GROUP

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Age Group
  • 6.2. Neonatal
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Adults
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country

CHAPTER 7: BILIRUBIN METERS MARKET, BY END USER

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By End User
  • 7.2. Hospitals And Nursing Home
    • 7.2.1. Key Market Trends, Growth Factors and Opportunities
    • 7.2.2. Market Size and Forecast, By Region
    • 7.2.3. Market Share Analysis, By Country
  • 7.3. Clinics
    • 7.3.1. Key Market Trends, Growth Factors and Opportunities
    • 7.3.2. Market Size and Forecast, By Region
    • 7.3.3. Market Share Analysis, By Country
  • 7.4. Others
    • 7.4.1. Key Market Trends, Growth Factors and Opportunities
    • 7.4.2. Market Size and Forecast, By Region
    • 7.4.3. Market Share Analysis, By Country

CHAPTER 8: BILIRUBIN METERS MARKET, BY REGION

  • 8.1. Market Overview
    • 8.1.1 Market Size and Forecast, By Region
  • 8.2. North America
    • 8.2.1. Key Market Trends and Opportunities
    • 8.2.2. Market Size and Forecast, By Product
    • 8.2.3. Market Size and Forecast, By Indication
    • 8.2.4. Market Size and Forecast, By Age Group
    • 8.2.5. Market Size and Forecast, By End User
    • 8.2.6. Market Size and Forecast, By Country
    • 8.2.7. U.S. Bilirubin Meters Market
      • 8.2.7.1. Market Size and Forecast, By Product
      • 8.2.7.2. Market Size and Forecast, By Indication
      • 8.2.7.3. Market Size and Forecast, By Age Group
      • 8.2.7.4. Market Size and Forecast, By End User
    • 8.2.8. Canada Bilirubin Meters Market
      • 8.2.8.1. Market Size and Forecast, By Product
      • 8.2.8.2. Market Size and Forecast, By Indication
      • 8.2.8.3. Market Size and Forecast, By Age Group
      • 8.2.8.4. Market Size and Forecast, By End User
    • 8.2.9. Mexico Bilirubin Meters Market
      • 8.2.9.1. Market Size and Forecast, By Product
      • 8.2.9.2. Market Size and Forecast, By Indication
      • 8.2.9.3. Market Size and Forecast, By Age Group
      • 8.2.9.4. Market Size and Forecast, By End User
  • 8.3. Europe
    • 8.3.1. Key Market Trends and Opportunities
    • 8.3.2. Market Size and Forecast, By Product
    • 8.3.3. Market Size and Forecast, By Indication
    • 8.3.4. Market Size and Forecast, By Age Group
    • 8.3.5. Market Size and Forecast, By End User
    • 8.3.6. Market Size and Forecast, By Country
    • 8.3.7. Germany Bilirubin Meters Market
      • 8.3.7.1. Market Size and Forecast, By Product
      • 8.3.7.2. Market Size and Forecast, By Indication
      • 8.3.7.3. Market Size and Forecast, By Age Group
      • 8.3.7.4. Market Size and Forecast, By End User
    • 8.3.8. France Bilirubin Meters Market
      • 8.3.8.1. Market Size and Forecast, By Product
      • 8.3.8.2. Market Size and Forecast, By Indication
      • 8.3.8.3. Market Size and Forecast, By Age Group
      • 8.3.8.4. Market Size and Forecast, By End User
    • 8.3.9. UK Bilirubin Meters Market
      • 8.3.9.1. Market Size and Forecast, By Product
      • 8.3.9.2. Market Size and Forecast, By Indication
      • 8.3.9.3. Market Size and Forecast, By Age Group
      • 8.3.9.4. Market Size and Forecast, By End User
    • 8.3.10. Italy Bilirubin Meters Market
      • 8.3.10.1. Market Size and Forecast, By Product
      • 8.3.10.2. Market Size and Forecast, By Indication
      • 8.3.10.3. Market Size and Forecast, By Age Group
      • 8.3.10.4. Market Size and Forecast, By End User
    • 8.3.11. Spain Bilirubin Meters Market
      • 8.3.11.1. Market Size and Forecast, By Product
      • 8.3.11.2. Market Size and Forecast, By Indication
      • 8.3.11.3. Market Size and Forecast, By Age Group
      • 8.3.11.4. Market Size and Forecast, By End User
    • 8.3.12. Rest of Europe Bilirubin Meters Market
      • 8.3.12.1. Market Size and Forecast, By Product
      • 8.3.12.2. Market Size and Forecast, By Indication
      • 8.3.12.3. Market Size and Forecast, By Age Group
      • 8.3.12.4. Market Size and Forecast, By End User
  • 8.4. Asia-Pacific
    • 8.4.1. Key Market Trends and Opportunities
    • 8.4.2. Market Size and Forecast, By Product
    • 8.4.3. Market Size and Forecast, By Indication
    • 8.4.4. Market Size and Forecast, By Age Group
    • 8.4.5. Market Size and Forecast, By End User
    • 8.4.6. Market Size and Forecast, By Country
    • 8.4.7. Japan Bilirubin Meters Market
      • 8.4.7.1. Market Size and Forecast, By Product
      • 8.4.7.2. Market Size and Forecast, By Indication
      • 8.4.7.3. Market Size and Forecast, By Age Group
      • 8.4.7.4. Market Size and Forecast, By End User
    • 8.4.8. China Bilirubin Meters Market
      • 8.4.8.1. Market Size and Forecast, By Product
      • 8.4.8.2. Market Size and Forecast, By Indication
      • 8.4.8.3. Market Size and Forecast, By Age Group
      • 8.4.8.4. Market Size and Forecast, By End User
    • 8.4.9. Australia Bilirubin Meters Market
      • 8.4.9.1. Market Size and Forecast, By Product
      • 8.4.9.2. Market Size and Forecast, By Indication
      • 8.4.9.3. Market Size and Forecast, By Age Group
      • 8.4.9.4. Market Size and Forecast, By End User
    • 8.4.10. India Bilirubin Meters Market
      • 8.4.10.1. Market Size and Forecast, By Product
      • 8.4.10.2. Market Size and Forecast, By Indication
      • 8.4.10.3. Market Size and Forecast, By Age Group
      • 8.4.10.4. Market Size and Forecast, By End User
    • 8.4.11. South Korea Bilirubin Meters Market
      • 8.4.11.1. Market Size and Forecast, By Product
      • 8.4.11.2. Market Size and Forecast, By Indication
      • 8.4.11.3. Market Size and Forecast, By Age Group
      • 8.4.11.4. Market Size and Forecast, By End User
    • 8.4.12. Rest of Asia-Pacific Bilirubin Meters Market
      • 8.4.12.1. Market Size and Forecast, By Product
      • 8.4.12.2. Market Size and Forecast, By Indication
      • 8.4.12.3. Market Size and Forecast, By Age Group
      • 8.4.12.4. Market Size and Forecast, By End User
  • 8.5. LAMEA
    • 8.5.1. Key Market Trends and Opportunities
    • 8.5.2. Market Size and Forecast, By Product
    • 8.5.3. Market Size and Forecast, By Indication
    • 8.5.4. Market Size and Forecast, By Age Group
    • 8.5.5. Market Size and Forecast, By End User
    • 8.5.6. Market Size and Forecast, By Country
    • 8.5.7. Brazil Bilirubin Meters Market
      • 8.5.7.1. Market Size and Forecast, By Product
      • 8.5.7.2. Market Size and Forecast, By Indication
      • 8.5.7.3. Market Size and Forecast, By Age Group
      • 8.5.7.4. Market Size and Forecast, By End User
    • 8.5.8. Saudi Arabia Bilirubin Meters Market
      • 8.5.8.1. Market Size and Forecast, By Product
      • 8.5.8.2. Market Size and Forecast, By Indication
      • 8.5.8.3. Market Size and Forecast, By Age Group
      • 8.5.8.4. Market Size and Forecast, By End User
    • 8.5.9. South Africa Bilirubin Meters Market
      • 8.5.9.1. Market Size and Forecast, By Product
      • 8.5.9.2. Market Size and Forecast, By Indication
      • 8.5.9.3. Market Size and Forecast, By Age Group
      • 8.5.9.4. Market Size and Forecast, By End User
    • 8.5.10. Rest of LAMEA Bilirubin Meters Market
      • 8.5.10.1. Market Size and Forecast, By Product
      • 8.5.10.2. Market Size and Forecast, By Indication
      • 8.5.10.3. Market Size and Forecast, By Age Group
      • 8.5.10.4. Market Size and Forecast, By End User

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top Winning Strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Top Player Positioning, 2023

CHAPTER 10: COMPANY PROFILES

  • 10.1. APEL Co. Ltd
    • 10.1.1. Company Overview
    • 10.1.2. Key Executives
    • 10.1.3. Company Snapshot
    • 10.1.4. Operating Business Segments
    • 10.1.5. Product Portfolio
    • 10.1.6. Business Performance
    • 10.1.7. Key Strategic Moves and Developments
  • 10.2. Dragerwerk AG And Co. KGaA
    • 10.2.1. Company Overview
    • 10.2.2. Key Executives
    • 10.2.3. Company Snapshot
    • 10.2.4. Operating Business Segments
    • 10.2.5. Product Portfolio
    • 10.2.6. Business Performance
    • 10.2.7. Key Strategic Moves and Developments
  • 10.3. Mennen Medical Ltd
    • 10.3.1. Company Overview
    • 10.3.2. Key Executives
    • 10.3.3. Company Snapshot
    • 10.3.4. Operating Business Segments
    • 10.3.5. Product Portfolio
    • 10.3.6. Business Performance
    • 10.3.7. Key Strategic Moves and Developments
  • 10.4. Micro Lab Instruments
    • 10.4.1. Company Overview
    • 10.4.2. Key Executives
    • 10.4.3. Company Snapshot
    • 10.4.4. Operating Business Segments
    • 10.4.5. Product Portfolio
    • 10.4.6. Business Performance
    • 10.4.7. Key Strategic Moves and Developments
  • 10.5. Ningbo David Medical Device Co. Ltd
    • 10.5.1. Company Overview
    • 10.5.2. Key Executives
    • 10.5.3. Company Snapshot
    • 10.5.4. Operating Business Segments
    • 10.5.5. Product Portfolio
    • 10.5.6. Business Performance
    • 10.5.7. Key Strategic Moves and Developments
  • 10.6. Siemens Healthineers AG
    • 10.6.1. Company Overview
    • 10.6.2. Key Executives
    • 10.6.3. Company Snapshot
    • 10.6.4. Operating Business Segments
    • 10.6.5. Product Portfolio
    • 10.6.6. Business Performance
    • 10.6.7. Key Strategic Moves and Developments
  • 10.7. Micro Labs Instruments
    • 10.7.1. Company Overview
    • 10.7.2. Key Executives
    • 10.7.3. Company Snapshot
    • 10.7.4. Operating Business Segments
    • 10.7.5. Product Portfolio
    • 10.7.6. Business Performance
    • 10.7.7. Key Strategic Moves and Developments
  • 10.8. AVI Healthcare Pvt Ltd
    • 10.8.1. Company Overview
    • 10.8.2. Key Executives
    • 10.8.3. Company Snapshot
    • 10.8.4. Operating Business Segments
    • 10.8.5. Product Portfolio
    • 10.8.6. Business Performance
    • 10.8.7. Key Strategic Moves and Developments
  • 10.9. F. Hoffmann-La Roche Ltd.
    • 10.9.1. Company Overview
    • 10.9.2. Key Executives
    • 10.9.3. Company Snapshot
    • 10.9.4. Operating Business Segments
    • 10.9.5. Product Portfolio
    • 10.9.6. Business Performance
    • 10.9.7. Key Strategic Moves and Developments
  • 10.10. Koninklijke Philips N.V.
    • 10.10.1. Company Overview
    • 10.10.2. Key Executives
    • 10.10.3. Company Snapshot
    • 10.10.4. Operating Business Segments
    • 10.10.5. Product Portfolio
    • 10.10.6. Business Performance
    • 10.10.7. Key Strategic Moves and Developments